Literature DB >> 15021321

Hepatotoxicity associated with nevirapine use.

Melisse Sloas Baylor, Rosemary Johann-Liang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15021321     DOI： 10.1097/00126334-200404150-00014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  22 in total

1.  The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.

Authors:  Vigneshwaran Namasivayam; Murugesan Vanangamudi; Victor G Kramer; Sonali Kurup; Peng Zhan; Xinyong Liu; Jacob Kongsted; Siddappa N Byrareddy
Journal:  J Med Chem       Date:  2018-12-27       Impact factor: 7.446

2.  Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

Authors:  Betty J Dong; Yu Zheng; Michael D Hughes; Adam Frymoyer; Davide Verotta; Patricia Lizak; Frederick Sawe; Judith S Currier; Shahin Lockman; Francesca T Aweeka
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 3.  Pharmacogenetics as a tool to tailor antiretroviral therapy: A review.

Authors:  Antonio Aceti; Laura Gianserra; Lara Lambiase; Alfredo Pennica; Elisabetta Teti
Journal:  World J Virol       Date:  2015-08-12

Review 4.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Authors:  Ann E Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

6.  Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.

Authors:  C William Wester; Ann Muir Thomas; Hermann Bussmann; Sikhulile Moyo; Joseph M Makhema; Tendani Gaolathe; Vladimir Novitsky; Max Essex; Victor deGruttola; Richard G Marlink
Journal:  AIDS       Date:  2010-01       Impact factor: 4.177

7.  Kidney transplantation in a patient with HIV disease.

Authors:  L I Gonzalez-Granado
Journal:  Indian J Nephrol       Date:  2009-07

8.  Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.

Authors:  Erika Aaron; Mirjam-Colette Kempf; Shannon Criniti; Ellen Tedaldi; Ed Gracely; Amy Warriner; Ritu Kumar; Laura H Bachmann
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

9.  Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.

Authors:  Patrick A Coffie; Besigin Tonwe-Gold; Aristophane K Tanon; Clarisse Amani-Bosse; Gédéon Bédikou; Elaine J Abrams; François Dabis; Didier K Ekouevi
Journal:  BMC Infect Dis       Date:  2010-06-24       Impact factor: 3.090

10.  Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.

Authors:  Carlo Torti; Silvia Costarelli; Annalisa De Silvestri; Eugenia Quiros-Roldan; Giuseppe Lapadula; Giuliana Cologni; Giuseppe Paraninfo; Filippo Castelnuovo; Massimo Puoti; Giampiero Carosi
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.